Kyowa KirinKyowa Kirin Co.,Ltd.4151東証プライム医薬品FY ending Dec 2025, consolidated, IFRS
Out of every ¥100 of sales, about ¥41 is left as operating profit. Revenue changed +0.3% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2021 | 14.9% | 0.38× | 5.7% | 1.25× | 7.1% |
| 2022 | 13.4% | 0.43× | 5.8% | 1.24× | 7.1% |
| 2023 | 18.4% | 0.45× | 8.3% | 1.23× | 10.2% |
| 2024 | 12.1% | 0.47× | 5.7% | 1.24× | 7.1% |
| 2025 | 13.5% | 0.46× | 6.2% | 1.25× | 7.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 352,246 | 398,371 | 442,233 | 495,558 | 496,826 |
| Cost of revenue | 87,849 | 86,915 | 111,207 | 132,611 | 127,934 |
| Gross profit | 264,398 | 311,455 | 331,026 | 362,947 | 368,892 |
| SG&A | 145,608 | 166,185 | 163,078 | 167,537 | 165,434 |
| Operating income | — | — | — | — | — |
| Pretax income | 60,050 | 67,572 | 97,246 | 83,453 | 87,221 |
| Income tax | 7,703 | 14,000 | 16,058 | 23,583 | 20,182 |
| Net income attributable to owners | 52,347 | 53,573 | 81,188 | 59,870 | 67,040 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥335.1B | ¥339.2B | ¥403.1B | ¥244.7B | ¥218.8B |
| Total assets | ¥921.9B | ¥939.9B | ¥1.03T | ¥1.07T | ¥1.11T |
| Net assets | ¥737.2B | ¥762.8B | ¥836.4B | ¥850.8B | ¥893.3B |
| Share capital | ¥26.7B | ¥26.7B | ¥26.7B | ¥26.7B | ¥26.7B |
| Property, plant and equipment | ¥78.7B | ¥89.1B | ¥94.5B | ¥111.5B | ¥141.2B |
| Goodwill | ¥136.4B | ¥135.8B | ¥140.4B | ¥181B | ¥183.5B |
| Current assets | ¥518.2B | ¥542.2B | ¥611.1B | ¥504B | ¥493.3B |
| Total liabilities | ¥184.7B | ¥177.1B | ¥189.5B | ¥216.6B | ¥214.5B |
| Equity attributable to owners of parent | ¥737.2B | ¥762.8B | ¥836.4B | ¥850.8B | ¥893.3B |
| Retained earnings | ¥255.5B | ¥285.8B | ¥338.8B | ¥371.1B | ¥406.3B |
| Treasury stock | -¥3.36B | -¥3.18B | -¥2.93B | -¥5.89B | -¥5.58B |
EDINET (FSA Japan)
有価証券報告書-第103期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第102期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第101期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第100期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第99期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第98期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 42 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.